Aardvark Therapeutics (AARD) Interest Income - Total (2024 - 2026)

Aardvark Therapeutics has reported Interest Income - Total for 3 years, with the latest figure at $889000.0 in Q1 2026.

• Quarterly Interest Income - Total fell 24.34% year-over-year to $889000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (up 39.21% YoY) and the FY2025 annual result came in at $5.1 million, up 112.88% from the prior year.
• Interest Income - Total slipped to $889000.0 in Q1 2026 per AARD's latest filing, from $1.1 million in the prior quarter.
• Over five years, Interest Income - Total peaked at $1.5 million in Q2 2025 and troughed at $103000.0 in Q1 2024.
• A 3-year average of $938000.0 and a median of $1.0 million in 2024 frame the typical range for Interest Income - Total.
• The sharpest annual moves came in 2025 and 2026: Interest Income - Total surged 1040.78% in 2025, then slipped 24.34% in 2026.
• Over 3 years, Interest Income - Total stood at $717000.0 in 2024, then jumped by 56.9% to $1.1 million in 2025, then slipped by 20.98% to $889000.0 in 2026.
• According to Business Quant data, Interest Income - Total over the past three periods registered $889000.0, $1.1 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.